西部證券(002673.SZ):擬向西部期貨增資3億元
格隆匯12月27日丨西部證券(002673.SZ)公佈,2021年12月27日,公司第五屆董事會第二十六次會議審議通過了《關於向西部期貨有限公司增資的提案》。
為落實公司“十四五”戰略規劃,支持子公司業務發展需要,會議同意以貨幣方式向全資子公司西部期貨有限公司(“西部期貨”)增資3億元人民幣,其中1億元人民幣由西部期貨以貨幣投資方式投向其風險管理子公司上海西部永唐投資管理有限公司用於支持其風險管理業務發展;其餘增資款將用於補充西部期貨淨資本、加大信息技術系統建設投入、優化經紀業務網點佈局、擴大自有資金投資等方面。此次增資授權公司經營管理層辦理相關手續,資金來源為公司募集資金。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.